Skip to main content
Top
Published in: Respiratory Research 1/2002

Open Access 01-06-2002 | Supplement

An epidemiological study of respiratory syncytial virus associated hospitalizations in Denmark

Author: Lone Graff Stensballe

Published in: Respiratory Research | Special Issue 1/2002

Login to get access

Abstract

Respiratory syncytial virus (RSV) is the most common viral pathogen that causes lower respiratory tract infections in infants. Studies have implicated severe RSV infections early in life as a risk factor for subsequent development of reactive airway disease. We are conducting a study to validate RSV-associated diagnoses in the Danish National Patient Registry, to assess whether the incidence of severe RSV infection is increasing in Denmark, to identify predisposing and protective factors for RSV-associated hospitalization in Denmark, and to examine the association of severe RSV infection with reactive airway disease. The influence of various biological, social and environmental factors on hospitalization for RSV infection will be studied through several population-based registers, including the Danish National Birth Cohort: 'Better health for mothers and children'. The RSV hospitalization cases will be compared with control individuals selected within the same population groups on a case–control or a cohort basis in order to produce estimates of age-adjusted and sex-adjusted relative risks (odds ratio and relative risk) for hospitalization associated with various risk factors. Using register linkage and unique registration of exposures collected through interviews and blood samples from the Danish National Birth Cohort, we will be able to resolve the issues referred to above in a very large sample of Danish children.
Literature
1.
go back to reference Chanock R, Roizman B, Myers R: Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). Am J Hyg 1957, 66:281–290.PubMed Chanock R, Roizman B, Myers R: Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). Am J Hyg 1957, 66:281–290.PubMed
2.
go back to reference Collins PL, Chanock RM, Murphy BR: Respiratory syncytial virus. In Fields Virology. (Edited by: Knipe DM, Howley PM). Philadelphia: Lippincott-Raven Publishers 2001, 1443–1485. Collins PL, Chanock RM, Murphy BR: Respiratory syncytial virus. In Fields Virology. (Edited by: Knipe DM, Howley PM). Philadelphia: Lippincott-Raven Publishers 2001, 1443–1485.
3.
go back to reference Selwyn BJ: The epidemiology of acute respiratory tract infection in young children: comparison of findings from several developing countries. Coordinated Data Group of BOSTID Researchers. Rev Infect Dis 1990,12(suppl 8):S870-S888.CrossRefPubMed Selwyn BJ: The epidemiology of acute respiratory tract infection in young children: comparison of findings from several developing countries. Coordinated Data Group of BOSTID Researchers. Rev Infect Dis 1990,12(suppl 8):S870-S888.CrossRefPubMed
4.
go back to reference Glezen P, Denny FW: Epidemiology of acute lower respiratory disease in children. N Engl J Med 1973, 288:498–505.CrossRefPubMed Glezen P, Denny FW: Epidemiology of acute lower respiratory disease in children. N Engl J Med 1973, 288:498–505.CrossRefPubMed
5.
go back to reference Meissner HC: Economic impact of viral respiratory disease in children. J Pediatr 1994, 124:S17-S21.CrossRefPubMed Meissner HC: Economic impact of viral respiratory disease in children. J Pediatr 1994, 124:S17-S21.CrossRefPubMed
6.
go back to reference Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ: Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA 1999, 282:1440–1446.CrossRefPubMed Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ: Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA 1999, 282:1440–1446.CrossRefPubMed
7.
go back to reference Kristensen K, Dahm T, Frederiksen PS, Ibsen J, Iyore E, Jensen AM, Kjaer BB, Olofsson K, Pedersen P, Poulsen S: Epidemiology of respiratory syncytial virus infection requiring hospitalization in East Denmark. Pediatr Infect Dis J 1998, 17:996–1000.CrossRefPubMed Kristensen K, Dahm T, Frederiksen PS, Ibsen J, Iyore E, Jensen AM, Kjaer BB, Olofsson K, Pedersen P, Poulsen S: Epidemiology of respiratory syncytial virus infection requiring hospitalization in East Denmark. Pediatr Infect Dis J 1998, 17:996–1000.CrossRefPubMed
8.
go back to reference Dessau RB, Schonheyder HC: Respiratory syncytial virus infection. A frequent child disease in Denmark with annual outbreaks [in Danish]. Ugeskr Laeger 1994, 156:1775–1779.PubMed Dessau RB, Schonheyder HC: Respiratory syncytial virus infection. A frequent child disease in Denmark with annual outbreaks [in Danish]. Ugeskr Laeger 1994, 156:1775–1779.PubMed
9.
go back to reference de Sierra TM, Kumar ML, Wasser TE, Murphy BR, Subbarao EK: Respiratory syncytial virus-specific immunoglobulins in preterm infants. J Pediatr 1993, 122:787–791.CrossRefPubMed de Sierra TM, Kumar ML, Wasser TE, Murphy BR, Subbarao EK: Respiratory syncytial virus-specific immunoglobulins in preterm infants. J Pediatr 1993, 122:787–791.CrossRefPubMed
10.
go back to reference Fixler DE: Respiratory syncytial virus infection in children with congenital heart disease: a review. Pediatr Cardiol 1996, 17:163–168.CrossRefPubMed Fixler DE: Respiratory syncytial virus infection in children with congenital heart disease: a review. Pediatr Cardiol 1996, 17:163–168.CrossRefPubMed
11.
go back to reference Abman SH, Ogle JW, Butler-Simon N, Rumack CM, Accurso FJ: Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J Pediatr 1988, 113:826–830.CrossRefPubMed Abman SH, Ogle JW, Butler-Simon N, Rumack CM, Accurso FJ: Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J Pediatr 1988, 113:826–830.CrossRefPubMed
12.
go back to reference Arnold SR, Wang EE, Law BJ, Boucher FD, Stephens D, Robinson JL, Dobson S, Langley JM, McDonald J, MacDonald NE, Mitchell I: Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada. Pediatr Infect Dis J 1999, 18:866–869.CrossRefPubMed Arnold SR, Wang EE, Law BJ, Boucher FD, Stephens D, Robinson JL, Dobson S, Langley JM, McDonald J, MacDonald NE, Mitchell I: Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada. Pediatr Infect Dis J 1999, 18:866–869.CrossRefPubMed
13.
go back to reference Hall CB, Powell KR, MacDonald NE, Gala CL, Menegus ME, Suffin SC, Cohen HJ: Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med 1986, 315:77–81.CrossRefPubMed Hall CB, Powell KR, MacDonald NE, Gala CL, Menegus ME, Suffin SC, Cohen HJ: Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med 1986, 315:77–81.CrossRefPubMed
14.
go back to reference Falsey AR, Treanor JJ, Betts RF, Walsh EE: Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings. J Am Geriatr Soc 1992, 40:115–119.CrossRefPubMed Falsey AR, Treanor JJ, Betts RF, Walsh EE: Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings. J Am Geriatr Soc 1992, 40:115–119.CrossRefPubMed
15.
go back to reference Falsey AR, Cunningham CK, Barker WH, Kouides RW, Yuen JB, Menegus M, Weiner LB, Bonville CA, Betts RF: Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis 1995, 172:389–394.CrossRefPubMed Falsey AR, Cunningham CK, Barker WH, Kouides RW, Yuen JB, Menegus M, Weiner LB, Bonville CA, Betts RF: Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis 1995, 172:389–394.CrossRefPubMed
16.
go back to reference Nachman SA, Navaie-Waliser M, Qureshi MZ: Rehospitalization with respiratory syncytial virus after neonatal intensive care unit discharge: a 3-year follow-up. Pediatrics 1997, 100:E8.CrossRefPubMed Nachman SA, Navaie-Waliser M, Qureshi MZ: Rehospitalization with respiratory syncytial virus after neonatal intensive care unit discharge: a 3-year follow-up. Pediatrics 1997, 100:E8.CrossRefPubMed
17.
go back to reference Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL: Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 1981, 98:708–715.CrossRefPubMed Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL: Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 1981, 98:708–715.CrossRefPubMed
18.
go back to reference Anderson LJ, Parker RA, Strikas RA, Farrar JA, Gangarosa EJ, Keyserling HL, Sikes RK: Day-care center attendance and hospitalization for lower respiratory tract illness. Pediatrics 1988, 82:300–308.PubMed Anderson LJ, Parker RA, Strikas RA, Farrar JA, Gangarosa EJ, Keyserling HL, Sikes RK: Day-care center attendance and hospitalization for lower respiratory tract illness. Pediatrics 1988, 82:300–308.PubMed
19.
go back to reference Trefny P, Stricker T, Baerlocher C, Sennhauser FH: Family history of atopy and clinical course of RSV infection in ambulatory and hospitalized infants. Pediatr Pulmonol 2000, 30:302–306.CrossRefPubMed Trefny P, Stricker T, Baerlocher C, Sennhauser FH: Family history of atopy and clinical course of RSV infection in ambulatory and hospitalized infants. Pediatr Pulmonol 2000, 30:302–306.CrossRefPubMed
20.
go back to reference Banzhoff A, Dulleck A, Petzoldt S, Rieger CH: Salivary anti-RSV IgA antibodies and respiratory infections during the first year of life in atopic and non-atopic infants. Pediatr Allergy Immunol 1994, 5:46–52.CrossRefPubMed Banzhoff A, Dulleck A, Petzoldt S, Rieger CH: Salivary anti-RSV IgA antibodies and respiratory infections during the first year of life in atopic and non-atopic infants. Pediatr Allergy Immunol 1994, 5:46–52.CrossRefPubMed
21.
go back to reference Holberg CJ, Wright AL, Martinez FD, Ray CG, Taussig LM, Lebowitz MD: Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am J Epidemiol 1991, 133:1135–1151.PubMed Holberg CJ, Wright AL, Martinez FD, Ray CG, Taussig LM, Lebowitz MD: Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am J Epidemiol 1991, 133:1135–1151.PubMed
22.
go back to reference Englund JA: Passive protection against respiratory syncytial virus disease in infants: the role of maternal antibody. Pediatr Infect Dis J 1994, 13:449–453.CrossRefPubMed Englund JA: Passive protection against respiratory syncytial virus disease in infants: the role of maternal antibody. Pediatr Infect Dis J 1994, 13:449–453.CrossRefPubMed
23.
24.
go back to reference Eriksson M, Bennet R, Nilsson A: Wheezing following lower respiratory tract infections with respiratory syncytial virus and influenza A in infancy. Pediatr Allergy Immunol 2000, 11:193–197.CrossRefPubMed Eriksson M, Bennet R, Nilsson A: Wheezing following lower respiratory tract infections with respiratory syncytial virus and influenza A in infancy. Pediatr Allergy Immunol 2000, 11:193–197.CrossRefPubMed
25.
go back to reference Castro-Rodriguez JA, Holberg CJ, Wright AL, Halonen M, Taussig LM, Morgan WJ, Martinez FD: Association of radiologically ascertained pneumonia before age 3 yr with asthmalike symptoms and pulmonary function during childhood: a prospective study. Am J Respir Crit Care Med 1999, 159:1891–1897.CrossRefPubMed Castro-Rodriguez JA, Holberg CJ, Wright AL, Halonen M, Taussig LM, Morgan WJ, Martinez FD: Association of radiologically ascertained pneumonia before age 3 yr with asthmalike symptoms and pulmonary function during childhood: a prospective study. Am J Respir Crit Care Med 1999, 159:1891–1897.CrossRefPubMed
26.
go back to reference McBride JT: Pulmonary function changes in children after respiratory syncytial virus infection in infancy. J Pediatr 1999, 135:28–32.CrossRefPubMed McBride JT: Pulmonary function changes in children after respiratory syncytial virus infection in infancy. J Pediatr 1999, 135:28–32.CrossRefPubMed
27.
go back to reference Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Bjorksten B: Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995, 95:500–505.PubMed Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Bjorksten B: Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995, 95:500–505.PubMed
28.
go back to reference Bendelja K, Gagro A, Bace A, Lokar-Kolbas R, Krsulovic-Hresic V, Drazenovic V, Mlinaric-Galinovic G, Rabatic S: Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry. Clin Exp Immunol 2000, 121:332–338.CrossRefPubMedPubMedCentral Bendelja K, Gagro A, Bace A, Lokar-Kolbas R, Krsulovic-Hresic V, Drazenovic V, Mlinaric-Galinovic G, Rabatic S: Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry. Clin Exp Immunol 2000, 121:332–338.CrossRefPubMedPubMedCentral
29.
go back to reference Boelen A, Andeweg A, Kwakkel J, Lokhorst W, Bestebroer T, Dormans J, Kimman T: Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice. Vaccine 2000, 19:982–991.CrossRefPubMed Boelen A, Andeweg A, Kwakkel J, Lokhorst W, Bestebroer T, Dormans J, Kimman T: Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice. Vaccine 2000, 19:982–991.CrossRefPubMed
30.
go back to reference Hanson LA, Dahlman-Hoglund A, Lundin S, Karlsson M, Dahlgren U, Ahlstedt S, Telemo E: Early determinants of immunocompetence. Nutr Rev 1997, 55:S12-S17.CrossRefPubMed Hanson LA, Dahlman-Hoglund A, Lundin S, Karlsson M, Dahlgren U, Ahlstedt S, Telemo E: Early determinants of immunocompetence. Nutr Rev 1997, 55:S12-S17.CrossRefPubMed
31.
go back to reference Marci M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E, Clerici M: Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996, 106:127–133.CrossRef Marci M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E, Clerici M: Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996, 106:127–133.CrossRef
32.
go back to reference Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG: Development of allergen-specific T-cell memory in atopic and normal children. Lancet 1999, 353:196–200.CrossRefPubMed Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG: Development of allergen-specific T-cell memory in atopic and normal children. Lancet 1999, 353:196–200.CrossRefPubMed
33.
go back to reference van dV, Laan MP, Baert MR, de Waal MR, Neijens HJ, Savelkoul HF: Selective development of a strong Th2 cytokine profile in high-risk children who develop atopy: risk factors and regulatory role of IFN-gamma, IL-4 and IL-10. Clin Exp Allergy 2001, 31:997–1006.CrossRef van dV, Laan MP, Baert MR, de Waal MR, Neijens HJ, Savelkoul HF: Selective development of a strong Th2 cytokine profile in high-risk children who develop atopy: risk factors and regulatory role of IFN-gamma, IL-4 and IL-10. Clin Exp Allergy 2001, 31:997–1006.CrossRef
34.
go back to reference Marchant A, Goetghebuer T, Ota MO, Wolfe I, Ceesay SJ, De Groote D, Corrah T, Bennett S, Wheeler J, Huygen K, Aaby P, McAdam KP, Newport MJ: Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J Immunol 1999, 163:2249–2255.PubMed Marchant A, Goetghebuer T, Ota MO, Wolfe I, Ceesay SJ, De Groote D, Corrah T, Bennett S, Wheeler J, Huygen K, Aaby P, McAdam KP, Newport MJ: Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J Immunol 1999, 163:2249–2255.PubMed
35.
go back to reference Aaby P, Shaheen SO, Heyes CB, Goudiaby A, Hall AJ, Shiell AW, Jensen H, Marchant A: Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin Exp Allergy 2000, 30:644–650.CrossRefPubMed Aaby P, Shaheen SO, Heyes CB, Goudiaby A, Hall AJ, Shiell AW, Jensen H, Marchant A: Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin Exp Allergy 2000, 30:644–650.CrossRefPubMed
36.
go back to reference Benn CS, Jeppesen DL, Hasselbalch H, Olesen AB, Nielsen J, Bjorksten B, Lisse I, Aaby P: Thymus size and head circumference at birth and the development of allergic diseases. Clin Exp Allergy 2001, 31:1862–1866.CrossRefPubMed Benn CS, Jeppesen DL, Hasselbalch H, Olesen AB, Nielsen J, Bjorksten B, Lisse I, Aaby P: Thymus size and head circumference at birth and the development of allergic diseases. Clin Exp Allergy 2001, 31:1862–1866.CrossRefPubMed
37.
go back to reference Droste JH, Wieringa MH, Weyler JJ, Nelen VJ, Vermeire PA, Van Bever HP: Does the use of antibiotics in early childhood increase the risk of asthma and allergic disease? Clin Exp Allergy 2000, 30:1547–1553.CrossRefPubMed Droste JH, Wieringa MH, Weyler JJ, Nelen VJ, Vermeire PA, Van Bever HP: Does the use of antibiotics in early childhood increase the risk of asthma and allergic disease? Clin Exp Allergy 2000, 30:1547–1553.CrossRefPubMed
38.
go back to reference Aaby P: Malnutrition and overcrowding/intensive exposure in severe measles infection: review of community studies. Rev Infect Dis 1988, 10:478–491.CrossRefPubMed Aaby P: Malnutrition and overcrowding/intensive exposure in severe measles infection: review of community studies. Rev Infect Dis 1988, 10:478–491.CrossRefPubMed
39.
go back to reference Aaby P: Influence of cross-sex transmission on measles mortality in rural Senegal. Lancet 1992, 340:388–391.CrossRefPubMed Aaby P: Influence of cross-sex transmission on measles mortality in rural Senegal. Lancet 1992, 340:388–391.CrossRefPubMed
40.
go back to reference Nielsen NM, Wohlfart J, Melbye M, Mølbak K, Aaby P: Does cross-sex transmission increase the severity of polio infection? A study of multiple family cases. Scand J Infect Dis 2002, 34:273–277.CrossRefPubMed Nielsen NM, Wohlfart J, Melbye M, Mølbak K, Aaby P: Does cross-sex transmission increase the severity of polio infection? A study of multiple family cases. Scand J Infect Dis 2002, 34:273–277.CrossRefPubMed
41.
go back to reference The IMpact-RSV Study Group: Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998, 102:531–537.CrossRef The IMpact-RSV Study Group: Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998, 102:531–537.CrossRef
42.
go back to reference Meissner HC, Welliver RC, Chartrand SA, Law BJ, Weisman LE, Dorkin HL, Rodriguez WJ: Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion. Pediatr Infect Dis J 1999, 18:223–231.CrossRefPubMed Meissner HC, Welliver RC, Chartrand SA, Law BJ, Weisman LE, Dorkin HL, Rodriguez WJ: Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion. Pediatr Infect Dis J 1999, 18:223–231.CrossRefPubMed
43.
go back to reference American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn: Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. Pediatrics 1998, 102:1211–1216.CrossRef American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn: Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. Pediatrics 1998, 102:1211–1216.CrossRef
44.
go back to reference Piedimonte G, King KA, Holmgren NL, Bertrand PJ, Rodriguez MM, Hirsch RL: A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways. Pediatr Res 2000, 47:351–356.CrossRefPubMed Piedimonte G, King KA, Holmgren NL, Bertrand PJ, Rodriguez MM, Hirsch RL: A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways. Pediatr Res 2000, 47:351–356.CrossRefPubMed
45.
go back to reference Stensballe LG, Kofoed PE, Nante EJ, Sambo M, Jensen IP, Aaby P: Duration of secretory IgM and IgA antibodies to respiratory syncytial virus in a community study in Guinea-Bissau. Acta Paediatr 2000, 89:421–426.CrossRefPubMed Stensballe LG, Kofoed PE, Nante EJ, Sambo M, Jensen IP, Aaby P: Duration of secretory IgM and IgA antibodies to respiratory syncytial virus in a community study in Guinea-Bissau. Acta Paediatr 2000, 89:421–426.CrossRefPubMed
46.
go back to reference World Health Organization: International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10). Geneva: World Health Organization; 1992. World Health Organization: International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10). Geneva: World Health Organization; 1992.
47.
go back to reference Department of Medical Informatics, The Danish National Health Service Guide to Speciality-Specific Coding and Registration of Clinical Diagnoses, 1st ed [in Danish]. Copenhagen: The Danish National Health Service; 1999. Department of Medical Informatics, The Danish National Health Service Guide to Speciality-Specific Coding and Registration of Clinical Diagnoses, 1st ed [in Danish]. Copenhagen: The Danish National Health Service; 1999.
Metadata
Title
An epidemiological study of respiratory syncytial virus associated hospitalizations in Denmark
Author
Lone Graff Stensballe
Publication date
01-06-2002
Publisher
BioMed Central
Published in
Respiratory Research / Issue Special Issue 1/2002
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/rr189

Other articles of this Special Issue 1/2002

Respiratory Research 1/2002 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine